Omeros Corporation (OMER) Financial Statements (2026 and earlier)

Company Profile

Business Address 201 ELLIOTT AVENUE WEST
SEATTLE, WA 98119
State of Incorp. WA
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:171,80036,10028,70052,40090,100123,200
Cash and cash equivalent9,6602,3951,9044,2613,4001,521
Short-term investments162,14433,69026,84048,15086,732121,636
Other undisclosed cash, cash equivalents, and short-term investments (4)15(44)(11)(32)43
Receivables10,9176,9086,2767,0767,7396,394
Inventory, net of allowances, customer advances and progress billings      
Inventory      
Other undisclosed current assets32,95028,79734,67136,70536,28135,327
Total current assets:215,66771,80569,64796,181134,120164,921
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization 1,287   2,025 
Operating lease, right-of-use asset10,70811,80712,89413,94814,96115,933
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization1,7682,0092,2392,4182,6781,939
Restricted cash and investments1,0541,0541,0541,0541,0541,054
Other undisclosed noncurrent assets95,14899,031114,735121,560122,241129,488
Total noncurrent assets:109,965113,901130,922138,980142,959148,414
TOTAL ASSETS:325,632185,706200,569235,161277,079313,335
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities34,15238,24435,11529,16531,91030,969
Accounts payable4,76412,4998,8384,4135,9057,723
Accrued liabilities29,38825,74526,27724,75226,00523,246
Debt 17,56617,03617,01726,92921,732 
Financial instruments subject to mandatory redemption, settlement terms, share value, amount   7,627   
Other undisclosed current liabilities26,34425,47625,74427,12825,88424,654
Total current liabilities:78,06280,75685,50383,22279,52655,623
Noncurrent Liabilities
Long-term debt and lease obligation52,085159,555150,787158,959167,825189,459
Long-term debt, excluding current maturities51,364159,555150,787158,959166,583189,459
Finance lease, liability 721   1,242 
Liabilities, other than long-term debt12,2264,5014,5014,50116,7253,094
Accounts payable and accrued liabilities5,7024,5014,5014,5014,5013,094
Operating lease, liability 6,524   12,224 
Derivative instruments and hedges, liabilities      
Total noncurrent liabilities:64,311164,056155,288163,460184,550192,553
Total liabilities:142,373244,812240,791246,682264,076248,176
Equity
Equity, attributable to parent(121,231)(220,478)(228,685)(213,553)(182,609)(154,172)
Common stock716700599580580579
Additional paid in capital791,748778,968739,945729,672727,156724,236
Accumulated deficit(913,695)(1,000,146)(969,229)(943,805)(910,345)(878,987)
Total equity:(121,231)(220,478)(228,685)(213,553)(182,609)(154,172)
Other undisclosed liabilities and equity304,490161,372188,463202,032195,612219,331
TOTAL LIABILITIES AND EQUITY:325,632185,706200,569235,161277,079313,335

Income Statement (P&L) ($ in thousands)

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
Revenues8285411411451364
Sublease income8285411411451364
Cost of revenue
(Cost of Product and Service Sold)
      
Gross profit:8285411411451364
Operating expenses(29,081)(26,392)(32,354)(34,969)(35,660)(35,407)
Other undisclosed operating loss (82)(85)(411)(411)(451)(364)
Operating loss:(29,081)(26,392)(32,354)(34,969)(35,660)(35,407)
Interest and debt expense(5,758)13,355(2,983)(3,654)(24,553)(26)
Other undisclosed income from continuing operations before equity method investments, income taxes 237,594     
Income (loss) from continuing operations before equity method investments, income taxes:202,755(13,037)(35,337)(38,623)(60,213)(35,433)
Other undisclosed income (loss) from continuing operations before income taxes(118,554)     
Income (loss) from continuing operations before income taxes:84,201(13,037)(35,337)(38,623)(60,213)(35,433)
Income tax expense      
Other undisclosed loss from continuing operations (2,012)     
Net income (loss):82,189(13,037)(35,337)(38,623)(60,213)(35,433)
Other undisclosed net income (loss) attributable to parent4,262(17,880)9,9135,16328,8553,201
Net income (loss) available to common stockholders, diluted:86,451(30,917)(25,424)(33,460)(31,358)(32,232)

Comprehensive Income ($ in thousands)

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
Net income (loss):82,189(13,037)(35,337)(38,623)(60,213)(35,433)
Comprehensive income (loss), net of tax, attributable to parent:82,189(13,037)(35,337)(38,623)(60,213)(35,433)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: